NASDAQ:EBACU

European Biotech Acquisition Stock Forecast, Price & News

$10.00
0.00 (0.00 %)
(As of 05/7/2021 12:00 AM ET)
Add
Compare
Today's Range
$9.98
$10.01
50-Day Range
$9.80
$10.15
52-Week Range
$9.77
$10.49
Volume261,213 shs
Average Volume95,029 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive EBACU News and Ratings via Email

Sign-up to receive the latest news and ratings for European Biotech Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry --
Sub-IndustryN/A
Sector--
Current SymbolNASDAQ:EBACU
CUSIPN/A
CIKN/A
WebN/A
Phone31 20 664 55 00
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual SalesN/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Headlines

See More Headlines

About European Biotech Acquisition

European Biotech Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2021 and is based in Amsterdam, the Netherlands.

MarketRank

Overall MarketRank

0.00 out of 5 stars

-- Sector

247th out of 273 stocks

-- Industry

249th out of 275 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











European Biotech Acquisition (NASDAQ:EBACU) Frequently Asked Questions

What stocks does MarketBeat like better than European Biotech Acquisition?

Wall Street analysts have given European Biotech Acquisition a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but European Biotech Acquisition wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are European Biotech Acquisition's key executives?

European Biotech Acquisition's management team includes the following people:
  • Mr. Eduardo Bravo Fernandez de Araoz, Chief Exec. Officer (Age 55)
  • Mr. Koen Sintnicolaas, Chief Financial Officer (Age 32)

Who are some of European Biotech Acquisition's key competitors?

When did European Biotech Acquisition IPO?

(EBACU) raised $100 million in an IPO on Tuesday, March 16th 2021. The company issued 10,000,000 shares at a price of $10.00 per share. Credit Suisse and Kempen & Co. served as the underwriters for the IPO.

What is European Biotech Acquisition's stock symbol?

European Biotech Acquisition trades on the NASDAQ under the ticker symbol "EBACU."

When did European Biotech Acquisition's quiet period expire?

European Biotech Acquisition's quiet period expired on Monday, April 26th. European Biotech Acquisition had issued 12,000,000 shares in its IPO on March 16th. The total size of the offering was $120,000,000 based on an initial share price of $10.00. During European Biotech Acquisition's quiet period, insiders and underwriters involved in the IPO were restricted from issuing any research reports for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

Who are European Biotech Acquisition's major shareholders?

European Biotech Acquisition's stock is owned by a variety of institutional and retail investors. Top institutional investors include Dupont Capital Management Corp (0.00%) and Exos Asset Management LLC (0.00%).

Which institutional investors are buying European Biotech Acquisition stock?

EBACU stock was bought by a variety of institutional investors in the last quarter, including Dupont Capital Management Corp, and Exos Asset Management LLC.

How do I buy shares of European Biotech Acquisition?

Shares of EBACU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is European Biotech Acquisition's stock price today?

One share of EBACU stock can currently be purchased for approximately $10.00.

How can I contact European Biotech Acquisition?

The company can be reached via phone at 31 20 664 55 00.


This page was last updated on 5/7/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.